You are currently viewing a new version of our website. To view the old version click .
Nutrients
  • Review
  • Open Access

14 December 2022

Omics as a Tool to Help Determine the Effectiveness of Supplements

,
and
Department of Animal Molecular Biology, National Research Institute of Animal Production, ul. Krakowska 1, 32-083 Balice, Poland
*
Author to whom correspondence should be addressed.
This article belongs to the Section Nutrition and Public Health

Abstract

There has been considerable interest in dietary supplements in the last two decades. Companies are releasing new specifics at an alarming pace, while dietary supplements are one of the less-studied substances released for public consumption. However, access to state-of-the-art and high-throughput techniques, such as the ones used in omics, make it possible to check the impact of a substance on human transcriptome or proteome and provide answers to whether its use is reasonable and beneficial. In this review, the main domains of omics are briefly introduced. The review focuses on the three most widely used omics techniques: NGS, LC-MS, NMR, and their usefulness in studying dietary supplements. Examples of studies are described for some of the most commonly supplemented substances, such as vitamins: D, E, A, and plant extracts: resveratrol, green tea, ginseng, and curcumin extract. Techniques used in omics have proven to be useful in studying dietary supplements. NGS techniques are helpful in identifying pathways that change upon supplementation and determining polymorphisms or conditions that qualify for the necessity of a given supplementation. LC-MS techniques are used to establish the serum content of supplemented a compound and its effects on metabolites. Both LC-MS and NMR help establish the actual composition of a compound, its primary and secondary metabolites, and its potential toxicity. Moreover, NMR techniques determine what conditions affect the effectiveness of supplementation.

1. Introduction

In the last 20 years, the interest and use of dietary supplements have significantly increased [1]. Consequently, much research has been conducted on the benefits of these substances, and a huge number of companies producing them have been created. However, there are many problems and challenges associated with dietary supplements, the first of which is the definition itself. The law defines dietary supplements in part as products taken by mouth that contain a “dietary ingredient”. Dietary ingredients include vitamins, minerals, amino acids, herbs or botanicals, and other substances that can be used to supplement the diet [2]. This is a broad and general definition. In addition, several other categories of products among different countries, such as natural health products (NHPs), complementary medicines, or food supplements, also fit this definition [3]. Another challenge is that each country, even among those with similar cultures, has different regulations regarding dietary supplements, and the same substance/mixture in one country can be labeled as a dietary supplement while in another it is considered a controlled substance. This makes it difficult for scientists to conduct consistent research and for consumers to choose an effective and high-quality product.
Another problem is the existence of significantly different views about the testing and control of dietary supplements. It can roughly be distinguished between two extreme approaches. Some are in favor of treating supplements as drugs, which would allow for a thorough examination of effectiveness, side effects, and appropriate doses, while others believe that supplements should be considered individually and less restrictively, which is due to, among others, the fact that the effects of many substances are assumed only on the basis of traditional knowledge [4]. Undoubtedly, corporations that produce supplements benefit from a large discrepancy, conflicting opinions, and the lack of uniform regulations. It is estimated that the supplement market in 2021 was worth USD 151.9 billion [5], and manufacturers are releasing new products at an alarming rate, sparing no money for marketing purposes [6]. This means that pharmacies and drugstores are full of easily accessible dietary supplements whose exact composition and potential effects have not been studied [7,8,9,10,11]. Those concerns are especially true with plant-derived supplements, which are the fastest growing segment of the supplements industry and face the biggest problems in terms of quality control and standardization [4,12,13]. All this indicates a very great need for scientific collaboration to overcome the aforementioned international problems [14,15]. Many state-of-the-art methods allow for a thorough examination of the ingredient identity, adulterants, and positive and negative impact of a given supplement on the body’s functioning, determining the appropriate doses for specific social groups or interactions with other substances, as we wanted to demonstrate in this overview [16,17].

2. Fields Studying the Influence of Substances on Various Levels of Life Organization

Omics are the branches of science encompassing multiple molecular disciplines that aim to collectively characterize global sets of biological molecules, such as DNAs, RNAs, proteins, and metabolites [18]. Therefore, among omics, we can distinguish basic disciplines e.g., genomics, transcriptomics, proteomics, or metabolomics, and fields that intersect several approaches and examine interactions between different components such as nutritional genomics and microbiomics, pharmacogenomics, or foodomics.

2.1. Genomics

An entry point for other sciences is genomics, which is a field of science focusing on the collective characterization of a whole-genome of an organism, including interactions of genes with each other and with the environment. Genomics began to develop dynamically after the publication of the human genome sequence in 2001 [19,20]. Nowadays, genomics primarily uses modern, high-throughput DNA-sequencing techniques, microarrays, and bioinformatics. In the area of genomics, there can also be distinguished other omics disciplines such as transcriptomics (which studies the complete set of RNA transcripts that are produced at given circumstances in an organism or a specific tissue or cell) and epigenomics (which studies a complete set of epigenomics modifications on a gene expression) [21]. Genomic studies mostly make use of next-generation sequencing techniques.

2.2. Nutritional Genomics

Thanks to Garrod, who studied alkaptonuria, the concept of the influence of interactions between nutrition and genetics on phenotype was already known at the beginning of the 20th century [22]. However, the evolution of genomics contributed to the initiation of research on the influence of dietary components on gene expression, initiating a new field of omics—nutritional genomics—, which consists of two parts: nutrigenomics and nutrigenetics. The term nutrigenomics was first used in 2001 by Peregrin in order “to sum up the future of nutritional science into a single word” [23]. However, nowadays, this phrase is used to describe the study of interactions between dietary components and the genome plus the resulting changes in protein level, metabolism regulation and overall homeostasis [24]. In the case of nutrigenetics, its purpose is to check the body’s response to dietary ingredients concerning genetic differences [25]. The analysis of the relationship between diet and genes conducted within nutritional genomics allows for the identification of mechanisms in which nutrition components affect health and the development of civilization diseases [26]. The first publications on nutritional genomics appeared at the beginning of the 90s and mainly concerned obesity issues, including the dietary fats genes interactions. At that time, it was hoped that it would be possible to identify obvious genetic and nutritional factors that increase the predisposition to be overweight, and, as a result, cardiovascular diseases or diabetes. Indeed, recent analyses, suggest that more than ninety single genetic variants (usually SNP) are involved in body fatness, through pathways within the central nervous system (regulations of food intake) or within pathways of lipid metabolism or adipogenesis [19]. Moreover, studies showed that the intake of sugar-sweetened beverages and fried food interacts with the genetic risk of obesity [27,28].
Currently, more studies are being conducted to understand the mechanisms of the action of bioactive components on genes at the molecular level. Bioactive components of the diet are signaling molecules that can interact with one or more compounds, and as a result affect, for example, the process of gene expression in a quantitative and qualitative sense, lead to some changes in the body’s physiological response to nutrients [29]. Bioactive ingredients act on two levels, either as chromatin structure regulators or as direct regulators of the activity of nuclear receptors [30,31]. In nutrigenomic experiments, in vitro conditions are mainly used, such as model cancer cells, and recently, the so-called organoids are created, for example, from stem cells, but also experimental animals such as the Caenorhabditis elegans or mice [19,31]. It is becoming obvious that there are complex interactions between the microbiome, the immune system, and the whole-body metabolism and that dietary components may modulate many of these dependencies [32]. The uses of nutrigenomics are multiple. For instance, it can help with personalized medicine and personalized diets by assessing an individual’s nutritional requirements in order to prevent or treat obesity, diabetes, and metabolic disorder. Omics disciplines mainly employed in nutrition research are transcriptomics, proteomics, and metabolomics [33].

2.3. Proteomics

Proteomics is a broad and complex field of science that, on a large-scale, study protein properties, such as their function, structure, expression level, post-translational modifications or interactions, to obtain a global picture of cellular processes, networks, and disease processes [34]. Overall, the focus of proteomics is on the proteome, which is a portmanteau of the words protein and genome first used in 1995 by Marc Wilkins, and it refers to the totality of the proteins present in the cell line, tissue, or organism during the entire life cycle [35,36]. The study of the proteome is much more complicated than the study of the transcriptome or genome because the amount of protein in the body is influenced not only by mRNA expression but also by post-translational modifications or the current physiological state of the cell. The techniques conventionally used to study proteins are several types of chromatography for purification, enzyme-linked immunosorbent assay (ELISA) or western blotting for analysis, and gel-based approaches such as sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) or two-dimensional gel electrophoresis (2-DE) for the separation of proteins. Nevertheless, when it comes to proteomics, high-throughput technologies such as protein microarrays, chips, mass spectrometry (MS) to analyze more complex protein mixtures, and X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy to provide a three-dimensional structure of the protein are more commonly used [37,38] These techniques provide a huge amount of data that require bioinformatic tools and databases to analyze, in order to predict the 2D and 3D structure of the tested proteins, interactions between them, and their response mechanism to various types of stresses, drugs, diseases, or dietary supplements.

2.4. Metabolomics

In the field of omics, we can also distinguish metabolomics, a dynamically developing area of science whose research goal is to identify and analyze the small endogenous and exogenous molecules (typically with sizes smaller than 1.5 kDa) called metabolites [39]. A complete set of substrates, intermediates, and products of metabolism in a cell, tissue, or organism is determined as a metabolome. Transcriptomic and proteomic analyses identify a comprehensive set of genes and their products being produced in the cell. Meanwhile, metabolomic studies can provide an insight into the current physiology of the cell [40]. In the late 1940s, Roger Williams’ research team developed the concept that every human being has his own “metabolic pattern” reflected by various components in body fluids components. This scientist, using paper chromatography, tested the presence of certain metabolites in urine and saliva, concluding that although the composition of these fluids varies from day to day and is distinctive from individual to individual, it is at the same time unique and characteristic to a given individual [41]. He conducted his research on samples taken from people suffering from, among others, alcoholism or schizophrenia and those staying in psychiatric hospitals, and he argued that each of these groups of people has a characteristic metabolic profile. Obviously, his research was mostly qualitative in nature. The real boom in the field of metabolomics took place about two decades later when more advanced techniques allowed for the quantitative description of tested samples [42]. Then, in 1971, Horning introduced the concept of the “metabolic profile”, after Dalgiesh proved that, by using gas chromatography-mass spectrometry (GC-MS), it is possible to measure the levels of components in physiological fluids and tissue extracts [43,44]. At the same time, NMR spectroscopy also gained importance in the study of the metabolome, thanks to Seeley, who in 1974 presented the usefulness of this technique to study metabolites in human tissues, proving, the basis of muscle that almost all ATP molecules are complexed with magnesium [45]. As with the genome or the proteome, the human metabolome was also examined in 2007 using previously mentioned variations of techniques—NMR and MS. The current version of The Human Metabolome Database (HMDB) contains information on 2280 drug metabolites, 25,000 human metabolic and disease pathways, and 28,000 food components and food additives [46].

2.5. Foodomics

The last category of omics discussed in this review is foodomics. It is a term first introduced in 2009 at the Cesena conference and is defined as a discipline that studies food and nutrients through the use and integration of advanced omics techniques. Such research aims to provide a more holistic understanding of the interactions between food and the functioning of the organisms and, at the same time, aims to take care of the quality and safety of food of both plant and animal origin, in order to improve consumer’s well-being and health [47,48]. Foodomics is the comprehensive approach for the exploitation of food science in light of an improvement of human nutrition; in this context, previously described nutrigenomics is considered a part of the more general term—foodomics [47]. Foodomics includes four sections of omics: genomics, transcriptomics, proteomics, and metabolomics. This field requires a combination of food chemistry, biological sciences, and high throughput analysis, which is why its research and development is still quite limited [49]. Foodomics techniques are useful from the production to the consumption of food, starting with analyses of raw material—(its microbiological and biological safety), through assessing the impact of food processing, to the quality and safety control in distribution and production. For instance, foodomics tools can detect possible allergens or foodborne pathogens in the product and in the case of side-effects caused by food, can identify causative agents or biomarkers, such as peptides or metabolites, that are relevant for tracking microbial infections or food allergies [48,50].

3. Molecular Techniques Most often Used in Omic Studies

In nutrigenomic research, it is necessary to precisely determine the influence of the tested substances on biological processes in the organism at the following levels: transcriptome, genome, proteome, and metabolome. Advanced, high-throughput techniques that generate a massive amount of data must be used to obtain a holistic view of a given subject. The most commonly used omic techniques are briefly described below.

3.1. NGS

It took over 12 years of hundreds of scientists’ work and cost almost USD 3 billion to obtain the sequence of the human genome [51].
The Human Genome Project relied on a first-generation sequencing technique called the Sanger technique, and although it allowed for the achievement of groundbreaking results, by the end of the project in 2002, it was known that a much more efficient, large-scale, and less expensive technique was needed, in order for these efforts to contribute to the development of genomic personalized medicine accessible for millions of patients [52]. Several years later, NGS (next-generation sequencing) techniques are in use, that overcome the limitation of Sanger sequencing methods and allow the entire genome to be sequenced in one day for about USD 1000 [53]. NGS-based tests rely on identifying the differences between the genome of the test sample and the reference genome. These differences may arrive from changes to the DNA sequence, e.g., single-nucleotide polymorphisms (SNPs), or large (the whole gene) deletions/duplications [52]. There are two major categories of NGS techniques, sequencing by hybridization and sequencing by synthesis (SBS), while the second approach is the predominant one [54]; therefore, the following descriptions focus on this method.
The basic NGS process involves three steps: library preparation which involves fragmenting DNA/RNA into multiple pieces and adding adapters (oligonucleotides of known sequence) at each end of the template fragments; then, sequencing of the library; and the last step is data analysis.
The vast majority of the sequencing data are generated using Illumina technology, where fragments of DNA with ligated adaptors at the ends, are hybridized to the flow cell surface and then amplified into a clonal cluster through bridge amplification cycles. Proprietary modified and fluorescently labeled nucleotides are incorporated and identified directly by fluorophore excitation during synthesis reactions. The process is repeated for at least 300 rounds. As all four reversible terminator dNTPs are present during each cycle, natural competition reduces incorporation bias and raw error rates. NGS platforms allow research of the genome, transcriptome, or epigenome of any organisms, with the use of a wide variety of methods such as whole-genome sequencing, de novo sequencing, targeted sequencing, total and mRNA sequencing, methylation sequencing or CHiP sequencing (chromatin immunoprecipitation sequencing) [55]. SBS methods rely on much shorter reads (up to 300–500 bases) and have an intrinsically higher error rate than Sanger sequencing. Another limitation of this approach is the reliance on high sequence coverage to obtain an accurate sequence [54].
Although typical, bulk RNA sequencing (RNA-seq) is extremely useful in studying gene expression, gene variants, alternative splicing, etc., and it illustrates an average of numerous cell transcriptomes present in the sample, disregarding the differences between individual cells. Therefore, shortly after introducing high-throughput RNA-seq, a technique for performing single-cell RNA-seq (scRNA-seq) emerged. This approach first requires tissue dissociation and then the isolation of single cells using fluorescence-activated cell sorting (FACS) or microfluidics-based techniques, or mechanical micromanipulation. The individual cells are lysed and converted into cDNA, which is the amplifier and is used to create RNA-seq libraries. scRNA-seq is successfully used in several fields, helping to study cancer heterogeneity and its microenvironment, immunology, neuroscience, and developmental biology [56]. It can also be useful in establishing the effect of a given factor on a particular type of cells, for instance, neurons or immune cells.
NGS techniques contributed to the rapid development and are now leading methods in omics fields such as genomics, transcriptomics, metagenomics, and nutritional genomics. NGS techniques can be used to determine human’ or animal’ genomes and can also be useful for both the qualitative and quantitative assessment and the identification of included in supplements species of, for instance, herbs. NGS techniques can also reveal a diverse community of fungi that are associated with live plant material [57].

3.2. LC/MS

Sometimes, a combination of several seemingly different techniques allows the discovery of their new possibilities and usefulness in many scientific fields. An example of such a successful combination is the LC-MS method, which combines the physical separation capabilities of liquid chromatography (LC) with the mass analysis capabilities of mass spectroscopy (MS). The coupling of chromatography and mass spectroscopy has been a subject of interest for over 60 years. The first one, reported in 1958 was a combination of gas chromatography (GC) with MS [58]. In GC, the analytes are eluted from the separation column as a gas and can be directly electrically (EI) or chemically (CI) ionized in order to produce mass spectra. This is not possible in the case of liquid chromatography; thus coupling LC with MS was technically a much more significant challenge, and hence it was not commercially available until the 1970s [58,59].
Nowadays, besides liquid chromatography and mass spectrometry devices, the LC-MS system also includes an interface based on atmospheric pressure ionization (API) strategies, that is used to transfer components from the LC column to the MS ion source. Therefore, the sample is pumped through the high-performance liquid chromatography (HPLC) column, where analytes move through at different migration rates. This step separates mixtures with multiple components such as biological fluids, drugs, food, or pesticides. Then, the eluent is directed to MS, where mass determines the mass-to-charge ratio of ions. These data can be used to determine the exact molecular mass that helps to establish the exact molecular mass and structural information about the components of such samples.
The LC-MS offers high selectivity, resolution, precise mass, and specificity compared to other chromatography techniques. However, at the same time, it is also expensive in terms of capital and running costs, and is high maintenance.
This method is used successfully in a variety of fields, for instance in proteomic or metabolomic studies for peptide mass fingerprinting, the metabolite profiling of human/animal tissue, and for the analysis of natural products or secondary metabolites in plants [60,61].

3.3. NMR

At the end of World War II, the nuclear magnetic resonance (NMR) phenomenon was discovered independently by two groups of scientists Felix Bloch and Edward Purcell. It began to be tested within just a few years, mainly in chemistry, leading to the observation that different compounds give different signals [62]. NMR is a physical event that occurs in all nuclei that contain an odd number of protons and/or neutrons (in other words: nonzero nuclear spin) (most frequently used are 1H and 13C), and it means that at a characteristic and specific resonance frequency it comes to the absorption and re-emission of electromagnetic radiation [63].
Nowadays, NMR spectroscopy is a powerful tool that can provide detailed and quantitative physical, chemical, electronic and structural information about molecules in solutions and in the solid state. Many varieties of NMR techniques have been developed, which are used in various fields, e.g., in medicine, in which the so-called magnetic resonance imaging (MRI) is used for cancer diagnosis, and in chemistry, where proton NMR is used to identify the constituent parts of compounds. Furthermore, NMR is also a leading technique in proteomics and metabolomics to obtain information from biological fluids about the state of the disease or the level of toxins, as well as in foodomics to measure, for example, the ratio between water and fat and a given food product [64]. However, it should be mentioned that the disadvantage of this method is its low sensitivity, which means that it can only be used for the detection and measurement of metabolites in relatively high concentrations [65].

5. Conclusions

Omics are areas of science that are considered essential to the holistic research and development of many vital issues, such as personalized medicine and the efficient and safe production of specific drugs. Techniques from the domain of omics should also be widely used in the study of dietary supplements. As shown in the examples in the review, the most commonly used omics techniques, such as NGS, LC-MS, and NMR, help investigate the molecular-level effect of a supplement in specific cases and its safe use. Variants of NGS techniques are most useful in establishing new potential effects of supplementation and in identifying signaling pathways and biological processes that are actually altered by the component. In addition, NGS allows the identification of groups of people, for example, with various polymorphisms or specific syndromes, which may be predisposed to a deficiency of a given compound and in which supplementation would have an actual, commensurate effect of bringing the organism to homeostasis. LC-MS techniques are most helpful in assessing the effects of various doses of the supplemented compound on metabolites and proteins. They are also used to measure the serum content of a given compound that would reflect the supplemented doses well. LC-MS techniques can also be used in studying the distribution and level of metabolites in compounds. Moreover, the variants of NMR techniques should be used to study metabolic changes and metabolic action pathways. They are also helpful in studying the potential toxicity of a compound. NMR can establish the exact composition of the compound, its sugar content, and primary and secondary metabolites. Moreover, those methods can be used to determine what conditions or individual characteristics may be affecting the effectiveness of supplementation. Therefore, by using these modern techniques and their combinations, the possibility of thoroughly examining the ingredients of dietary supplements and determining for whom such supplementation may be useful or necessary, and at the same time safe, become widely available.

Author Contributions

Conceptualization, A.S., M.O. and G.S.; writing—original draft preparation, A.S.; writing—review and editing, M.O. and G.S.; funding acquisition, M.O. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by National Science Centre (2019/35/O/NZ9/03148., 10.2020-09.2024).

Institutional Review Board Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Kantor, E.D.; Rehm, C.D.; Du, M.; White, E.; Giovannucci, E.L. Trends in Dietary Supplement Use Among US Adults From 1999–2012. JAMA 2016, 316, 1464. [Google Scholar] [CrossRef] [PubMed]
  2. FDA Consumer Updates. Available online: https://www.fda.gov/consumers/consumer-updates/fda-101-dietary-supplements (accessed on 10 October 2021).
  3. Dwyer, J.T.; Coates, P.M.; Smith, M.J. Dietary supplements: Regulatory challenges and research resources. Nutrients 2018, 10, 41. [Google Scholar] [CrossRef] [PubMed]
  4. Fu, P.P.; Chiang, H.M.; Xia, Q.; Chen, T.; Chen, B.H.; Yin, J.J.; Wen, K.C.; Lin, G.; Yu, H. Quality assurance and safety of herbal dietary supplements. J. Environ. Sci. Health Part C Environ. Carcinog. Ecotoxicol. Rev. 2009, 27, 91–119. [Google Scholar] [CrossRef] [PubMed]
  5. Dietary Supplements Market Size, Share & Trends Analysis Report by Ingredient (Vitamins, Minerals), by Form, by Application, by End User, by Distribution Channel, by Region, and Segment Forecasts 2022–2030. Available online: https://www.grandviewresearch.com/industry-analysis/dietary-supplements-market (accessed on 15 March 2022).
  6. Kesselheim, A.S.; Connolly, J.; Rogers, J.; Avorn, J. Mandatory disclaimers on dietary supplements do not reliably communicate the intended issues. Health Aff. 2015, 34, 438–446. [Google Scholar] [CrossRef]
  7. Denham, B.E. Dietary supplements—Regulatory issues and implications for public health. JAMA 2011, 306, 428–429. [Google Scholar] [CrossRef] [PubMed]
  8. Deuster, P.A.; Lindsey, A.T.; Scott, J.M. Dietary supplements: Regulatory challenges and issues in the department of defense. Mil. Med. 2018, 183, 53–55. [Google Scholar] [CrossRef]
  9. Pawar, R.S.; Grundel, E. Overview of regulation of dietary supplements in the USA and issues of adulteration with phenethylamines (PEAs). Drug Test. Anal. 2017, 9, 500–517. [Google Scholar] [CrossRef]
  10. Petroczi, A.; Taylor, G.; Naughton, D.P. Mission impossible? Regulatory and enforcement issues to ensure safety of dietary supplements. Food Chem. Toxicol. 2011, 49, 393–402. [Google Scholar] [CrossRef]
  11. Tucker, J.; Fischer, T.; Upjohn, L.; Mazzera, D.; Kumar, M. Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings. JAMA Netw. Open 2018, 1, e183337. [Google Scholar] [CrossRef]
  12. Brown, A.C. An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series. Food Chem. Toxicol. 2017, 107, 449–471. [Google Scholar] [CrossRef]
  13. Ratajczak, M.; Kaminska, D.; Światły-Błaszkiewicz, A.; Matysiak, J. Quality of dietary supplements containing plant-derived ingredients reconsidered by microbiological approach. Int. J. Environ. Res. Public Health 2020, 17, 6837. [Google Scholar] [CrossRef] [PubMed]
  14. Cicero, A.F.G.; Ferroni, A.; Ertek, S. Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects. Expert Opin. Drug Saf. 2012, 11, 753–766. [Google Scholar] [CrossRef]
  15. Maughan, R.J. Quality assurance issues in the use of dietary supplements, with special reference to protein supplements. J. Nutr. 2013, 143, 1843S–1847S. [Google Scholar] [CrossRef] [PubMed]
  16. Faller, A.C.; Arunachalam, T.; Shanmughanandhan, D.; Kesanakurti, P.; Shehata, H.R.; Ragupathy, S.; Newmaster, S.G. Investigating appropriate molecular and chemical methods for ingredient identity testing of plant-based protein powder dietary supplements. Sci. Rep. 2019, 9, 12130. [Google Scholar] [CrossRef] [PubMed]
  17. Crighton, E.; Coghlan, M.L.; Farrington, R.; Hoban, C.L.; Power, M.W.P.; Nash, C.; Mullaney, I.; Byard, R.W.; Trengove, R.; Musgrave, I.F.; et al. Toxicological screening and DNA sequencing detects contamination and adulteration in regulated herbal medicines and supplements for diet, weight loss and cardiovascular health. J. Pharm. Biomed. Anal. 2019, 176, 112834. [Google Scholar] [CrossRef] [PubMed]
  18. Micheel, C.M.; Nass, S.J.; Omenn, G.S.; Policy, H.S. Evolution of Translational Omics; Micheel, C.M., Nass, S.J., Omenn, G.S., Eds.; National Academies Press: Washington, DC, USA, 2012; ISBN 978-0-309-22418-5. [Google Scholar]
  19. Mathers, J.C. Nutrigenomics in the modern era. Proc. Nutr. Soc. 2017, 76, 265–275. [Google Scholar] [CrossRef]
  20. Craig Venter, J.; Adams, M.D.; Myers, E.W.; Li, P.W.; Mural, R.J.; Sutton, G.G.; Smith, H.O.; Yandell, M.; Evans, C.A.; Holt, R.A.; et al. The sequence of the human genome. Science 2001, 291, 1304–1351. [Google Scholar] [CrossRef]
  21. Kaur, S. Genomics. In Brenner’s Encyclopedia of Genetics, 2nd ed.; Elsevier: Amsterdam, The Netherlands, 2013; pp. 310–312. [Google Scholar] [CrossRef]
  22. Garrod, A.E. The incidence of alkaptonuria: A study in chemical individuality. Mol. Med. 1996, 2, 274–282. [Google Scholar] [CrossRef]
  23. Peregrin, T. The new frontier of nutrition science: Nutrigenomics. J. Am. Diet. Assoc. 2001, 101, 1306. [Google Scholar] [CrossRef]
  24. Ekmekci, A.; Cirak, M.Y. Nutrigenomics and nutrigenetics. Adv. Food Biochem. 2009, 457–475. [Google Scholar] [CrossRef]
  25. Subbiah, M.T.R. Nutrigenetics and nutraceuticals: The next wave riding on personalized medicine. Transl. Res. 2007, 149, 55–61. [Google Scholar] [CrossRef] [PubMed]
  26. Chadwick, R. Nutrigenomics, individualism and public health. Proc. Nutr. Soc. 2004, 63, 161–166. [Google Scholar] [CrossRef] [PubMed]
  27. Qi, Q.; Chu, A.Y.; Kang, J.H.; Jensen, M.K.; Curhan, G.C.; Pasquale, L.R.; Ridker, P.M.; Hunter, D.J.; Willett, W.C.; Rimm, E.B.; et al. Sugar-Sweetened Beverages and Genetic Risk of Obesity. N. Engl. J. Med. 2012, 367, 1387–1396. [Google Scholar] [CrossRef] [PubMed]
  28. Qi, Q.; Chu, A.Y.; Kang, J.H.; Huang, J.; Rose, L.M.; Jensen, M.K.; Liang, L.; Curhan, G.C.; Pasquale, L.R.; Wiggs, J.L.; et al. Fried food consumption, genetic risk, and body mass index: Gene-diet interaction analysis in three US cohort studies. BMJ 2014, 348, g1610. [Google Scholar] [CrossRef] [PubMed]
  29. Guaadaoui, A.; Benaicha, S.; Elmajdoub, N.; Bellaoui, M.; Hamal, A. What is a bioactive compound? A combined definition for a preliminary consensus. Int. J. Food Sci. Nutr. 2014, 3, 17–179. [Google Scholar] [CrossRef]
  30. Fenech, M. Genome health nutrigenomics and nutrigenetics—diagnosis and nutritional treatment of genome damage on an individual basis. Food Chem. Toxicol. 2008, 46, 1365–1370. [Google Scholar] [CrossRef]
  31. Gȩtek, M.; Czech, N.; Fizia, K.; Białek-Dratwa, A.; Muc-Wierzgoń, M.; Kokot, T.; Nowakowska-Zajdel, E. Nutrigenomika—Bioaktywne składniki żywności. Postep. Hig. Med. Dosw. 2013, 67, 255–260. [Google Scholar] [CrossRef]
  32. Verma, M.; Hontecillas, R.; Abedi, V.; Leber, A.; Tubau-Juni, N.; Philipson, C.; Carbo, A.; Bassaganya-Riera, J. Modeling-Enabled Systems Nutritional Immunology. Front. Nutr. 2016, 3, 5. [Google Scholar] [CrossRef][Green Version]
  33. Kato, H.; Takahashi, S.; Saito, K. Omics and integrated omics for the promotion of food and nutrition science. J. Tradit. Complement. Med. 2011, 1, 25–30. [Google Scholar] [CrossRef]
  34. Blackstock, W.P.; Weir, M.P. Proteomics: Quantitative and physical mapping of cellular proteins. Trends Biotechnol. 1999, 17, 121–127. [Google Scholar] [CrossRef]
  35. Wasinger, V.C.; Cordwell, S.J.; Poljak, A.; Yan, J.X.; Gooley, A.A.; Wilkins, M.R.; Duncan, M.W.; Harris, R.; Williams, K.L.; Humphery-Smith, I. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 1995, 16, 1090–1094. [Google Scholar] [CrossRef] [PubMed]
  36. Anderson, N.L.; Anderson, N.G. Proteome and proteomics: New technologies, new concepts, and new words. Electrophoresis 1998, 19, 1853–1861. [Google Scholar] [CrossRef]
  37. Zhang, Z.; Wu, S.; Stenoien, D.L.; Paša-Tolić, L. High-throughput proteomics. Annu. Rev. Anal. Chem. 2014, 7, 427–454. [Google Scholar] [CrossRef] [PubMed]
  38. Aslam, B.; Basit, M.; Nisar, M.A.; Khurshid, M.; Rasool, M.H. Proteomics: Technologies and their applications. J. Chromatogr. Sci. 2017, 55, 182–196. [Google Scholar] [CrossRef] [PubMed]
  39. Stobiecki, M. Metabolomika—narzędzie w genomice funkcjonalnej i biologii systemów. Biotechnologia 2009, 2, 54–64. [Google Scholar]
  40. Hollywood, K.; Brison, D.R.; Goodacre, R. Metabolomics: Current technologies and future trends. Proteomics 2006, 6, 4716–4723. [Google Scholar] [CrossRef]
  41. Gates, S.C.; Sweeley, C.C. Quantitative metabolic profiling based on gas chromatography. Clin. Chem. 1978, 24, 1663–1673. [Google Scholar] [CrossRef]
  42. Novotny, M.V.; Soini, H.A.; Mechref, Y. Biochemical individuality reflected in chromatographic, electrophoretic and mass-spectrometric profiles. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2008, 866, 26–47. [Google Scholar] [CrossRef]
  43. Dalgliesh, C.; Horning, E.; Horning, M.; Knox, K.; Yarger, K. A gas-liquid-chromatographic procedure for separating a wide range of metabolites occurring in urine or tissue extracts. Biochem. J. 1966, 101, 792–810. [Google Scholar] [CrossRef]
  44. Horning, E.C.; Horning, M.G. Human metabolic profiles obtained by gc and gc/ms. J. Chromatogr. Sci. 1971, 9, 129–140. [Google Scholar] [CrossRef]
  45. Wishart, D.S.; Tzur, D.; Knox, C.; Eisner, R.; Guo, A.C.; Young, N.; Cheng, D.; Jewell, K.; Arndt, D.; Sawhney, S.; et al. HMDB: The human metabolome database. Nucleic Acids Res. 2007, 35, 521–526. [Google Scholar] [CrossRef]
  46. Wishart, D.S.; Feunang, Y.D.; Marcu, A.; Guo, A.C.; Liang, K.; Vázquez-Fresno, R.; Sajed, T.; Johnson, D.; Li, C.; Karu, N.; et al. HMDB 4.0: The human metabolome database for 2018. Nucleic Acids Res. 2018, 46, D608–D617. [Google Scholar] [CrossRef] [PubMed]
  47. Cifuentes, A. Food analysis and foodomics. J. Chromatogr. A 2009, 1216, 7109. [Google Scholar] [CrossRef]
  48. Andjelković, U.; Gajdošik, M.Š.; Gašo-Sokač, D.; Martinović, T.; Josić, D. Foodomics and food safety: Where we are. Food Technol. Biotechnol. 2017, 55, 290–307. [Google Scholar] [CrossRef]
  49. Capozzi, F.; Bordoni, A. Foodomics: A new comprehensive approach to food and nutrition. Genes Nutr. 2013, 8, 1–4. [Google Scholar] [CrossRef] [PubMed]
  50. Giacometti, J.; Josic, D. Foodomics in microbial safety. TrAC Trends Anal. Chem. 2013, 52, 16–22. [Google Scholar] [CrossRef]
  51. National Human Genome Research Institute. Human Genome Project FAQ, National Institute of Health. 2010. Available online: https://www.genome.gov/11006943/human-genome-project-completion-frequently-asked-questions/ (accessed on 8 January 2021).
  52. Muzzey, D.; Evans, E.A.; Lieber, C. Understanding the Basics of NGS: From Mechanism to Variant Calling. Curr. Genet. Med. Rep. 2015, 3, 158–165. [Google Scholar] [CrossRef] [PubMed]
  53. Metzker, M.L. Sequencing technologies the next generation. Nat. Rev. Genet. 2010, 11, 31–46. [Google Scholar] [CrossRef] [PubMed]
  54. Slatko, B.E.; Gardner, A.F.; Ausubel, F.M. Overview of Next-Generation Sequencing Technologies. Curr. Protoc. Mol. Biol. 2018, 122, e59. [Google Scholar] [CrossRef]
  55. Sequencing Technology Sequencing by Synthesis. Available online: https://www.illumina.com/science/technology/next-generation-sequencing/sequencing-technology.html (accessed on 25 November 2021).
  56. Olsen, T.K.; Baryawno, N. Introduction to Single-Cell RNA Sequencing. Curr. Protoc. Mol. Biol. 2018, 122, e57. [Google Scholar] [CrossRef] [PubMed]
  57. Ivanova, N.V.; Kuzmina, M.L.; Braukmann, T.W.A.; Borisenko, A.V.; Zakharov, E.V. Authentication of herbal supplements using next-generation sequencing. PLoS ONE 2016, 11, e0156426. [Google Scholar] [CrossRef] [PubMed]
  58. Chatfield, D.A.; Fitzgerald, R.L. Liquid Chromatography—Mass Spectrometry: An Introduction; Ardrey, R.E., Ed.; Wiley: Hoboken, NJ, USA, 2003; Volume 50, p. 276. ISBN 0471497991. [Google Scholar]
  59. Pitt, J.J. Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry. Clin. Biochem. Rev. 2009, 30, 19–34. [Google Scholar]
  60. Stobiecki, M.; Skirycz, A.; Kerhoas, L.; Kachlicki, P.; Muth, D.; Einhorn, J.; Mueller-Roeber, B. Profiling of phenolic glycosidic conjugates in leaves of Arabidopsis thaliana using LC/MS. Metabolomics 2006, 2, 197–219. [Google Scholar] [CrossRef]
  61. Gika, H.G.; Theodoridis, G.A.; Plumb, R.S.; Wilson, I.D. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics. J. Pharm. Biomed. Anal. 2014, 87, 12–25. [Google Scholar] [CrossRef] [PubMed]
  62. Marion, D. An introduction to biological NMR spectroscopy. Mol. Cell. Proteom. 2013, 12, 3006–3025. [Google Scholar] [CrossRef] [PubMed]
  63. Rhodes, C.J. Magnetic resonance spectroscopy. Sci. Prog. 2017, 100, 241–292. [Google Scholar] [CrossRef]
  64. Rinck, P. Magnetic Resonance in Medicine. In The Basic Textbook of the European Magnetic Resonance Forum, 11th ed.; Wiley: Hoboken, NJ, USA, 2017. [Google Scholar]
  65. Horgan, R.P.; Kenny, L.C. ‘Omic’ technologies: Genomics, transcriptomics, proteomics and metabolomics. Obstet. Gynaecol. 2011, 13, 189–195. [Google Scholar] [CrossRef]
  66. Panossian, A.; Wikman, G.; Wagner, H. Plant adaptogens III. Earlier and more recent aspects and concepts on their mode of action. Phytomedicine 1999, 6, 287–300. [Google Scholar] [CrossRef]
  67. Dobson, R.; Cock, H.R.; Brex, P.; Giovannoni, G. Vitamin D supplementation. Pract. Neurol. 2018, 18, 35–42. [Google Scholar] [CrossRef]
  68. Collagen and Magnesium Rise in Popularity, as Fish Oil and Curcumin Dip in Latest ConsumerLab Survey of Supplement Users. Available online: https://www.consumerlab.com/news/most-popular-supplements-from-survey/02-29-2020/ (accessed on 11 April 2022).
  69. Panel, E.; Nda, A. Scientific Opinion on Dietary Reference Values for niacin. EFSA J. 2014, 12, 3759. [Google Scholar] [CrossRef]
  70. Ross, C.; Taylor, C.L.; Yaktine, A.L. Dietary Reference Intakes for Calcium and Vitamin D; National Academies Press: Washington, DC, USA, 2011; ISBN 978-0-309-16394-1. [Google Scholar]
  71. Best, C.M.; Riley, D.V.; Laha, T.J.; Pflaum, H.; Zelnick, L.R.; Hsu, S.; Thummel, K.E.; Foster-Schubert, K.E.; Kuzma, J.N.; Cromer, G.; et al. Vitamin D in human serum and adipose tissue after supplementation. Am. J. Clin. Nutr. 2021, 113, 83–91. [Google Scholar] [CrossRef]
  72. Barger-Lux, M.J.; Heaney, R.P.; Dowell, S.; Chen, T.C.; Holick, M.F. Vitamin D and its Major Metabolites: Serum Levels after Graded Oral Dosing in Healthy Men. Osteoporos. Int. 1998, 8, 222–230. [Google Scholar] [CrossRef]
  73. Chen, T.C.; Turner, A.K.; Holick, M.F. A method for the determination of the circulating concentration of 1,25-dihydroxyvitamin D. J. Nutr. Biochem. 1990, 1, 320–327. [Google Scholar] [CrossRef]
  74. Heaney, R.P.; Davies, K.M.; Chen, T.C.; Holick, M.F.; Janet Barger-Lux, M. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 2003, 77, 204–210. [Google Scholar] [CrossRef] [PubMed]
  75. Norman, A.W. From vitamin D to hormone D: Fundamentals of the vitamin D endocrine system essential for good health. Am. J. Clin. Nutr. 2008, 88, 491S–499S. [Google Scholar] [CrossRef] [PubMed]
  76. Galior, K.; Ketha, H.; Grebe, S.; Singh, R.J. 10 years of 25-hydroxyvitamin-D testing by LC-MS/MS-trends in vitamin-D deficiency and sufficiency. Bone Rep. 2018, 8, 268–273. [Google Scholar] [CrossRef] [PubMed]
  77. Medeiros, J.F.P.; de Oliveira Borges, M.V.; Soares, A.A.; dos Santos, J.C.; de Oliveira, A.B.B.; da Costa, C.H.B.; Cruz, M.S.; Bortolin, R.H.; de Freitas, R.C.C.; Dantas, P.M.S.; et al. The impact of vitamin D supplementation on VDR gene expression and body composition in monozygotic twins: Randomized controlled trial. Sci. Rep. 2020, 10, 11943. [Google Scholar] [CrossRef]
  78. Durrant, L.R.; Bucca, G.; Hesketh, A.; Möller-Levet, C.; Tripkovic, L.; Wu, H.; Hart, K.H.; Mathers, J.C.; Elliott, R.M.; Lanham-New, S.A.; et al. Vitamins D2 and D3 Have Overlapping But Different Effects on the Human Immune System Revealed Through Analysis of the Blood Transcriptome. Front. Immunol. 2022, 13. [Google Scholar] [CrossRef]
  79. Vaughan-Shaw, P.G.; Grimes, G.; Blackmur, J.P.; Timofeeva, M.; Walker, M.; Ooi, L.Y.; Svinti, V.; Donnelly, K.; Din, F.V.N.; Farrington, S.M.; et al. Oral vitamin D supplementation induces transcriptomic changes in rectal mucosa that are linked to anti-tumour effects. BMC Med. 2021, 19, 174. [Google Scholar] [CrossRef]
  80. Pasing, Y.; Fenton, C.G.; Jorde, R.; Paulssen, R.H. Changes in the Human Transcriptome upon Vitamin D Supplementation; Elsevier Ltd.: Amsterdam, The Netherlands, 2017; Volume 173, ISBN 2007002167. [Google Scholar]
  81. Dastorani, M.; Aghadavod, E.; Mirhosseini, N.; Foroozanfard, F.; Zadeh Modarres, S.; Amiri Siavashani, M.; Asemi, Z. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization. Reprod. Biol. Endocrinol. 2018, 16, 94. [Google Scholar] [CrossRef]
  82. Makieva, S.; Reschini, M.; Ferrari, S.; Bonesi, F.; Polledri, E.; Fustinoni, S.; Restelli, L.; Sarais, V.; Somigliana, E.; Viganò, P. Oral Vitamin D supplementation impacts gene expression in granulosa cells in women undergoing IVF. Hum. Reprod. 2021, 36, 130–144. [Google Scholar] [CrossRef] [PubMed]
  83. Garand, M.; Toufiq, M.; Singh, P.; Huang, S.S.Y.; Tomei, S.; Mathew, R.; Mattei, V.; Al Wakeel, M.; Sharif, E.; Al Khodor, S. Immunomodulatory effects of vitamin d supplementation in a deficient population. Int. J. Mol. Sci. 2021, 22, 5041. [Google Scholar] [CrossRef]
  84. Claro da Silva, T.; Hiller, C.; Gai, Z.; Kullak-Ublick, G.A. Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor. J. Steroid Biochem. Mol. Biol. 2016, 163, 77–87. [Google Scholar] [CrossRef]
  85. Seuter, S.; Virtanen, J.K.; Nurmi, T.; Pihlajamäki, J.; Mursu, J.; Voutilainen, S.; Tuomainen, T.P.; Neme, A.; Carlberg, C. Molecular evaluation of vitamin D responsiveness of healthy young adults. J. Steroid Biochem. Mol. Biol. 2017, 174, 314–321. [Google Scholar] [CrossRef]
  86. Carlberg, C.; Seuter, S.; Nurmi, T.; Tuomainen, T.P.; Virtanen, J.K.; Neme, A. In vivo response of the human epigenome to vitamin D: A Proof-of-principle study. J. Steroid Biochem. Mol. Biol. 2018, 180, 142–148. [Google Scholar] [CrossRef]
  87. McClorry, S.; Slupsky, C.M.; Lind, T.; Karlsland Åkeson, P.; Hernell, O.; Öhlund, I. Effectiveness of vitamin D supplementation in Swedish children may be negatively impacted by BMI and serum fructose. J. Nutr. Biochem. 2020, 75, 108251. [Google Scholar] [CrossRef] [PubMed]
  88. Zumaraga, M.P.; Medina, P.J.; Recto, J.M.; Abrahan, L.; Azurin, E.; Tanchoco, C.C.; Jimeno, C.A.; Palmes-Saloma, C. Targeted next generation sequencing of the entire vitamin D receptor gene reveals polymorphisms correlated with vitamin D deficiency among older Filipino women with and without fragility fracture. J. Nutr. Biochem. 2017, 41, 98–108. [Google Scholar] [CrossRef]
  89. Zumaraga, M.P.; Concepcion, M.A.; Duante, C.; Rodriguez, M. Next generation sequencing of 502 lifestyle and nutrition related genetic polymorphisms reveals independent loci for low serum 25-hydroxyvitamin d levels among adult respondents of the 2013 philippine national nutrition survey. J. ASEAN Fed. Endocr. Soc. 2021, 36, 56–63. [Google Scholar] [CrossRef] [PubMed]
  90. Barker, B. Vitamin E Supplementation in People with Cystic Fibrosis: Summary of a Cochrane Review; Explore: New York, NY, USA, 2021. [Google Scholar] [CrossRef]
  91. Institute of Medicine (US). Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids, Proceedings of the Panel on Dietary Antioxidants and Related Compounds; National Academies Press: Washington, DC, USA, 2000; Volume 2, ISBN 978-0-309-06935-9. [Google Scholar]
  92. Klein, E.A.; Thompson, I.M.; Tangen, C.M.; Crowley, J.J.; Lucia, M.S.; Goodman, P.J.; Minasian, L.M.; Ford, L.G.; Parnes, H.L.; Gaziano, J.M.; et al. Vitamin E and the Risk of Prostate Cancer. JAMA 2011, 306, 1549. [Google Scholar] [CrossRef]
  93. Heinonen, O.P.; Albanes, D.; Virtamo, J.; Taylor, P.R.; Huttunen, J.K.; Hartman, A.M.; Haapakoski, J.; Malila, N.; Rautalahti, M.; Ripatti, S.; et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: Incidence and mortality in a controlled trial. J. Natl. Cancer Inst. 1998, 90, 440–446. [Google Scholar] [CrossRef]
  94. Huang, J.; Hodis, H.N.; Weinstein, S.J.; Mack, W.J.; Sampson, J.N.; Mondul, A.M.; Albanes, D. Serum Metabolomic Response to Low- and High-Dose Vitamin E Supplementation in Two Randomized Controlled Trials. Cancer Epidemiol. Biomark. Prev. 2020, 29, 1329–1334. [Google Scholar] [CrossRef] [PubMed]
  95. Costacou, T.; Levy, A.P.; Miller, R.G.; Snell-Bergeon, J.; Asleh, R.; Farbstein, D.; Fickley, C.E.; Pambianco, G.; de la Vega, R.; Evans, R.W.; et al. Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: Results from the HapE randomized crossover pilot trial. Acta Diabetol. 2016, 53, 243–250. [Google Scholar] [CrossRef] [PubMed]
  96. Zinder, R.; Cooley, R.; Vlad, L.G.; Molnar, J.A. Vitamin A and Wound Healing. Nutr. Clin. Pract. 2019, 34, 839–849. [Google Scholar] [CrossRef] [PubMed]
  97. Wirth, J.P.; Petry, N.; Tanumihardjo, S.A.; Rogers, L.M.; McLean, E.; Greig, A.; Garrett, G.S.; Klemm, R.D.W.; Rohner, F. Vitamin a supplementation programs and country-level evidence of vitamin A deficiency. Nutrients 2017, 9, 190. [Google Scholar] [CrossRef] [PubMed]
  98. Ferreira Faustino, J.; Ribeiro-Silva, A.; Faeda Dalto, R.; Martins De Souza, M.; Fortes Furtado, J.M.; de Melo Rocha, G.; Alves, M.; Melani Rocha, E. Vitamin A and the eye: An old tale for modern times. Arq. Bras. Oftalmol. 2016, 79, 56–61. [Google Scholar] [CrossRef] [PubMed]
  99. Saeed, A.; Dullaart, R.P.F.; Schreuder, T.C.M.A.; Blokzijl, H.; Faber, K.N. Disturbed vitamin A metabolism in non-alcoholic fatty liver disease (NAFLD). Nutrients 2018, 10, 29. [Google Scholar] [CrossRef]
  100. Piersma, A.H.; Hessel, E.V.; Staal, Y.C. Retinoic acid in developmental toxicology: Teratogen, morphogen and biomarker. Reprod. Toxicol. 2017, 72, 53–61. [Google Scholar] [CrossRef]
  101. McGrane, M.M. Vitamin A regulation of gene expression: Molecular mechanism of a prototype gene. J. Nutr. Biochem. 2007, 18, 497–508. [Google Scholar] [CrossRef]
  102. Bar-El Dadon, S.; Reifen, R. Vitamin A and the epigenome. Crit. Rev. Food Sci. Nutr. 2017, 57, 2404–2411. [Google Scholar] [CrossRef]
  103. Wang, Y.; Song, X.; Geng, Y. Effects of IC50 dose of retinol on metabolomics of RAW264.7 cells. J. Food Biochem. 2020, 44, e13090. [Google Scholar] [CrossRef]
  104. Novelle, M.G.; Wahl, D.; Diéguez, C.; Bernier, M.; de Cabo, R. Resveratrol supplementation: Where are we now and where should we go? Ageing Res. Rev. 2015, 21, 1–15. [Google Scholar] [CrossRef] [PubMed]
  105. Shaito, A.; Posadino, A.M.; Younes, N.; Hasan, H.; Halabi, S.; Alhababi, D.; Al-Mohannadi, A.; Abdel-Rahman, W.M.; Eid, A.H.; Nasrallah, G.K.; et al. Potential adverse effects of resveratrol: A literature review. Int. J. Mol. Sci. 2020, 21, 2084. [Google Scholar] [CrossRef] [PubMed]
  106. Wu, H.; Chen, L.; Zhu, F.; Han, X.; Sun, L.; Chen, K. The cytotoxicity effect of resveratrol: Cell cycle arrest and induced apoptosis of breast cancer 4T1 cells. Toxins 2019, 11, 731. [Google Scholar] [CrossRef]
  107. Zhou, J.; Liao, Z.; Jia, J.; Chen, J.L.; Xiao, Q. The effects of resveratrol feeding and exercise training on the skeletal muscle function and transcriptome of aged rats. PeerJ 2019, 2019, e7199. [Google Scholar] [CrossRef] [PubMed]
  108. Lv, Z.M.; Ling, M.Y.; Chen, C. Comparative proteomics reveals protective effect of resveratrol on a high-fat diet-induced damage to mice testis. Syst. Biol. Reprod. Med. 2020, 66, 37–49. [Google Scholar] [CrossRef]
  109. Chen, X.; Wang, Y.; Tian, J.; Shao, Y.; Zhu, B.; Wang, J.; Hua, Z. Quantitative Chemical Proteomics Reveals Resveratrol Inhibition of A549 Cell Migration Through Binding Multiple Targets to Regulate Cytoskeletal Remodeling and Suppress EMT. Front. Pharmacol. 2021, 12, 636213. [Google Scholar] [CrossRef] [PubMed]
  110. Wang, C.; Chen, Z.; Zhao, X.; Lin, C.; Hong, S.; Lou, Y.; Shi, X.; Zhao, M.; Yang, X.; Guan, M.X.; et al. Transcriptome-based analysis reveals therapeutic effects of resveratrol on endometriosis in arat model. Drug Des. Devel. Ther. 2021, 15, 4141–4155. [Google Scholar] [CrossRef] [PubMed]
  111. Ramalingam, P.; Ko, Y.T. Validated LC-MS/MS method for simultaneous quantification of resveratrol levels in mouse plasma and brain and its application to pharmacokinetic and brain distribution studies. J. Pharm. Biomed. Anal. 2016, 119, 71–75. [Google Scholar] [CrossRef]
  112. Guo, T.; Song, D.; Ho, C.T.; Zhang, X.; Zhang, C.; Cao, J.; Wu, Z. Omics Analyses of Gut Microbiota in a Circadian Rhythm Disorder Mouse Model Fed with Oolong Tea Polyphenols. J. Agric. Food Chem. 2019, 67, 8847–8854. [Google Scholar] [CrossRef]
  113. Zhang, Y.; Cheng, L.; Liu, Y.; Zhang, R.; Wu, Z.; Cheng, K.; Zhang, X. Omics Analyses of Intestinal Microbiota and Hypothalamus Clock Genes in Circadian Disturbance Model Mice Fed with Green Tea Polyphenols. J. Agric. Food Chem. 2022, 70, 1890–1901. [Google Scholar] [CrossRef]
  114. Prasanth, M.I.; Sivamaruthi, B.S.; Chaiyasut, C.; Tencomnao, T. A review of the role of green tea (camellia sinensis) in antiphotoaging, stress resistance, neuroprotection, and autophagy. Nutrients 2019, 11, 474. [Google Scholar] [CrossRef]
  115. Sellami, M.; Slimeni, O.; Pokrywka, A.; Kuvačić, G.; Hayes, L.D.; Milic, M.; Padulo, J. Herbal medicine for sports: A review. J. Int. Soc. Sport. Nutr. 2018, 15, 14. [Google Scholar] [CrossRef]
  116. Xing, L.; Zhang, H.; Qi, R.; Tsao, R.; Mine, Y. Recent Advances in the Understanding of the Health Benefits and Molecular Mechanisms Associated with Green Tea Polyphenols. J. Agric. Food Chem. 2019, 67, 1029–1043. [Google Scholar] [CrossRef]
  117. Seeram, N.P.; Henning, S.M.; Niu, Y.; Lee, R.; Scheuller, H.S.; Heber, D. Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity. J. Agric. Food Chem. 2006, 54, 1599–1603. [Google Scholar] [CrossRef] [PubMed]
  118. Zang, L.; Shimada, Y.; Nakayama, H.; Kim, Y.; Chu, D.C.; Juneja, L.R.; Kuroyanagi, J.; Nishimura, N. RNA-seq based transcriptome analysis of the anti-obesity effect of green tea extract using zebrafish obesity models. Molecules 2019, 24, 3256. [Google Scholar] [CrossRef]
  119. Choi, J.Y.; Kim, Y.J.; Ryu, R.; Cho, S.J.; Kwon, E.Y.; Choi, M.S. Effect of green tea extract on systemic metabolic homeostasis in diet-induced obese mice determined via RNA-seq transcriptome profiles. Nutrients 2016, 8, 640. [Google Scholar] [CrossRef]
  120. Jia, L.; Zhao, Y.; Liang, X.-J. Current Evaluation of the Millennium Phytomedicine- Ginseng (II): Collected Chemical Entities, Modern Pharmacology, and Clinical Applications Emanated from Traditional Chinese Medicine. Curr. Med. Chem. 2009, 16, 2924–2942. [Google Scholar] [CrossRef]
  121. Kim, S.W.; Gupta, R.; Lee, S.H.; Min, C.W.; Agrawal, G.K.; Rakwal, R.; Kim, J.B.; Jo, I.H.; Park, S.Y.; Kim, J.K.; et al. An integrated biochemical, proteomics, and metabolomics approach for supporting medicinal value of Panax ginseng fruits. Front. Plant Sci. 2016, 7, 994. [Google Scholar] [CrossRef]
  122. Wang, J.; Hou, Y.; Jia, Z.; Xie, X.; Liu, J.; Kang, Y.; Wang, X.; Wang, X.; Jia, W. Metabonomics Approach to Comparing the Antistress Effects of Four Panax ginseng Components in Rats. J. Proteome Res. 2018, 17, 813–821. [Google Scholar] [CrossRef] [PubMed]
  123. Panossian, A.; Abdelfatah, S.; Efferth, T. Network pharmacology of ginseng (Part ii): The differential effects of red ginseng and ginsenoside rg5 in cancer and heart diseases as determined by transcriptomics. Pharmaceuticals 2021, 14, 1010. [Google Scholar] [CrossRef] [PubMed]
  124. Park, M.; Kim, K.H.; Jaiswal, V.; Choi, J.; Chun, J.L.; Seo, K.M.; Lee, M.J.; Lee, H.J. Effect of black ginseng and silkworm supplementation on obesity, the transcriptome, and the gut microbiome of diet-induced overweight dogs. Sci. Rep. 2021, 11, 8002. [Google Scholar] [CrossRef] [PubMed]
  125. Wang, D.; Lv, L.; Xu, Y.; Jiang, K.; Chen, F.; Qian, J.; Chen, M.; Liu, G.; Xiang, Y. Cardioprotection of Panax Notoginseng saponins against acute myocardial infarction and heart failure through inducing autophagy. Biomed. Pharmacother. 2021, 136, 111287. [Google Scholar] [CrossRef] [PubMed]
  126. Smith, I.; Williamson, E.M.; Putnam, S.; Farrimond, J.; Whalley, B.J. Effects and mechanisms of ginseng and ginsenosides on cognition. Nutr. Rev. 2014, 72, 319–333. [Google Scholar] [CrossRef] [PubMed]
  127. Xiang, Y.-Z.; Shang, H.-C.; Gao, X.-M.; Zhang, B.-L. A Comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials. Phytother. Res. 2008, 22, 851–858. [Google Scholar] [CrossRef]
  128. Multum, C. Ginseng as a Drug—General Information. Available online: https://www.drugs.com/mtm/ginseng.html (accessed on 13 December 2022).
  129. Yang, S.O.; Shin, Y.S.; Hyun, S.H.; Cho, S.; Bang, K.H.; Lee, D.; Choi, S.P.; Choi, H.K. NMR-based metabolic profiling and differentiation of ginseng roots according to cultivation ages. J. Pharm. Biomed. Anal. 2012, 58, 19–26. [Google Scholar] [CrossRef]
  130. Yoon, D.; Shin, W.C.; Lee, Y.S.; Kim, S.; Baek, N.I.; Lee, D.Y. A Comparative Study on Processed Panax ginseng Products Using HR-MAS NMR-Based Metabolomics. Molecules 2020, 25, 1390. [Google Scholar] [CrossRef]
  131. Yoon, D.; Choi, B.R.; Kim, Y.C.; Oh, S.M.; Kim, H.G.; Kim, J.U.; Baek, N.I.; Kim, S.; Lee, D.Y. Comparative analysis of panax ginseng berries from seven cultivars using UPLC-QTOF/MS and nmr-based metabolic profiling. Biomolecules 2019, 9, 362. [Google Scholar] [CrossRef]
  132. D’Aguanno, S.; D’Agnano, I.; De Canio, M.; Rossi, C.; Bernardini, S.; Federici, G.; Urbani, A. Shotgun proteomics and network analysis of neuroblastoma cell lines treated with curcumin. Mol. Biosyst. 2012, 8, 1068–1077. [Google Scholar] [CrossRef]
  133. Cooney, J.M.; Barnett, M.P.G.; Dommels, Y.E.M.; Brewster, D.; Butts, C.A.; McNabb, W.C.; Laing, W.A.; Roy, N.C. A combined omics approach to evaluate the effects of dietary curcumin on colon inflammation in the Mdr1a-/- mouse model of inflammatory bowel disease. J. Nutr. Biochem. 2016, 27, 181–192. [Google Scholar] [CrossRef]
  134. Huminiecki, L.; Horbańczuk, J.; Atanasov, A.G. The functional genomic studies of curcumin. Semin. Cancer Biol. 2017, 46, 107–118. [Google Scholar] [CrossRef]
  135. Gouda, M.M.; Rex, D.A.B.; Es, S.P.; Modi, P.K.; Chanderasekaran, J.; Bhandary, Y.P. Proteomics Analysis Revealed the Importance of Inflammation-Mediated Downstream Pathways and the Protective Role of Curcumin in Bleomycin-Induced Pulmonary Fibrosis in C57BL/6 Mice. J. Proteome Res. 2020, 19, 2950–2963. [Google Scholar] [CrossRef]
  136. Li, L.; Zhang, Z.; Huang, Y. Integrative transcriptome analysis and discovery of signaling pathways involved in the protective effects of curcumin against oxidative stress in tilapia hepatocytes. Aquat. Toxicol. 2020, 224, 105516. [Google Scholar] [CrossRef] [PubMed]
  137. Huang, X.; Liang, C.; Yang, H.; Li, X.; Deng, X.; Liang, X.; Li, L.; Huang, Z.; Lu, D.; Ma, Y.; et al. Curcumin induces apoptosis and inhibits the growth of adrenocortical carcinoma: Identification of potential candidate genes and pathways by transcriptome analysis. Oncol. Lett. 2021, 21, 476. [Google Scholar] [CrossRef] [PubMed]
  138. Nelson, K.M.; Dahlin, J.L.; Bisson, J.; Graham, J.; Pauli, G.F.; Walters, M.A. The Essential Medicinal Chemistry of Curcumin. J. Med. Chem. 2017, 60, 1620–1637. [Google Scholar] [CrossRef] [PubMed]
  139. Menon, V.P.; Sudheer, A.R. Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol. 2007, 595, 105–125. [Google Scholar] [CrossRef] [PubMed]
  140. Kotha, R.R.; Luthria, D.L. Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects. Molecules 2019, 24, 2930. [Google Scholar] [CrossRef]
  141. Nelson, K.M.; Dahlin, J.L.; Bisson, J.; Graham, J.; Pauli, G.F.; Walters, M.A. Curcumin May (Not) Defy Science. ACS Med. Chem. Lett. 2017, 8, 467–470. [Google Scholar] [CrossRef]
  142. Bashang, H.; Tamma, S. The use of curcumin as an effective adjuvant to cancer therapy: A short review. Biotechnol. Appl. Biochem. 2020, 67, 171–179. [Google Scholar] [CrossRef]
  143. Sadeghian, M.; Rahmani, S.; Jamialahmadi, T.; Johnston, T.P.; Sahebkar, A. The effect of oral curcumin supplementation on health-related quality of life: A systematic review and meta-analysis of randomized controlled trials. J. Affect. Disord. 2021, 278, 627–636. [Google Scholar] [CrossRef]
  144. Lestari, M.L.A.D.; Indrayanto, G. Curcumin. In Profiles of Drug Substances, Excipients and Related Methodology; Elsevier: Amsterdam, The Netherlands, 2014; Volume 39, ISBN 9780128001738. [Google Scholar]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.